Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:822144rdf:typepubmed:Citationlld:pubmed
pubmed-article:822144lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:822144lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:822144lifeskim:mentionsumls-concept:C0011880lld:lifeskim
pubmed-article:822144lifeskim:mentionsumls-concept:C0549178lld:lifeskim
pubmed-article:822144lifeskim:mentionsumls-concept:C0199782lld:lifeskim
pubmed-article:822144pubmed:issue4lld:pubmed
pubmed-article:822144pubmed:dateCreated1976-11-1lld:pubmed
pubmed-article:822144pubmed:abstractTextTwelve diabetic children--eight in ketoacidosis, three with insulin refractory hyperglycemia, and one postoperative patient--were treated with continuous, low-dose, intravenous infusion of insulin. The eight ketoacidotic children with a mean serum glucose concentration on admission of 631 mg/dl and bicarbonate value of 6.8 mM/1 were given regular insulin, 0.1 U/kg, slowly by bolus injection followed by a sustaining infusion of 0.1 U/kg/hour. Plasma glucose concentration fell at a mean rate of 82 mg/dl/hour. Euglycemia with concomitant improvement in the metabolic disorder was achieved with a mean dose of insulin, 0.68 U/kg, given over four to 10 hours. Mean plasma insulin in those children who had not previously received insulin was 55 muU/ml, well within the normal physiologic range. Growth hormone and serum triglyceride levels, low initially, rose with insulin therapy before returning to control values. Continuous low-dose insulin infusion is simple, safe, and effective, avoids confusion and empiricism, and appears to be the method of choice for the treatment of diabetic ketoacidosis or insulin resistance.lld:pubmed
pubmed-article:822144pubmed:languageenglld:pubmed
pubmed-article:822144pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:822144pubmed:citationSubsetAIMlld:pubmed
pubmed-article:822144pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:822144pubmed:statusMEDLINElld:pubmed
pubmed-article:822144pubmed:monthOctlld:pubmed
pubmed-article:822144pubmed:issn0022-3476lld:pubmed
pubmed-article:822144pubmed:authorpubmed-author:MartinM MMMlld:pubmed
pubmed-article:822144pubmed:authorpubmed-author:MartinA AAAlld:pubmed
pubmed-article:822144pubmed:issnTypePrintlld:pubmed
pubmed-article:822144pubmed:volume89lld:pubmed
pubmed-article:822144pubmed:ownerNLMlld:pubmed
pubmed-article:822144pubmed:authorsCompleteYlld:pubmed
pubmed-article:822144pubmed:pagination560-4lld:pubmed
pubmed-article:822144pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-H...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-A...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-C...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-I...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-C...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-F...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-M...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-D...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-I...lld:pubmed
pubmed-article:822144pubmed:meshHeadingpubmed-meshheading:822144-H...lld:pubmed
pubmed-article:822144pubmed:year1976lld:pubmed
pubmed-article:822144pubmed:articleTitleContinuous low-dose infusion of insulin in the treatment of diabetic ketoacidosis in children.lld:pubmed
pubmed-article:822144pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:822144pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:822144lld:pubmed